Skip to content

    M B Agro Prod.

    MBAPL
    Chemicals·12 Jan 2026
    Management Summary

    Madhya Bharat Agro Products Limited delivered a robust Q3 FY26, achieving record revenue and profitability driven by strong demand and operational efficiency. The company is making significant strides in its capacity expansion projects in Dhule and Sagar, with commercialization anticipated in FY27. While overall margins were affected by lower-margin imported products, the company maintains strong profitability on its manufactured goods and expects continued growth momentum.

    Highlights

    5
    • Revenue of ₹612.4 crores, up 115.9% YoY, marking the highest ever quarterly revenue.

    • EBITDA of ₹66.5 crores, up 68.4% YoY, also the highest ever.

    • PAT grew 77.7% to ₹31.8 crores, reflecting strong profitability.

    • Record fertilizer production volumes of 1,34,355 MT and high capacity utilization (SSP at 109%, NPK/DAP at 115%).

    • Dhule and Sagar expansion projects are on track for commissioning in FY27, promising future growth.

    Concerns

    2
    • Overall EBITDA margins were impacted, appearing lower due to the inclusion of lower-margin imported products (2.5-3% vs 13-14% for own production).

    • Inventory buildup occurred due to temporary logistics issues, though expected to be resolved within the quarter.

    What Changed1

    vs Q4 FY26

    Guidance items11 → 8 (-3)
    Key financials

    Metrics

    10

    Periods

    2

    Q3 FY26

    6
    • Revenue
      ₹612.4 Cr
      YoY+115.9%
    • EBITDA
      ₹66.5 Cr
      YoY+68.4%
    • PAT
      ₹31.8 Cr
      YoY+77.7%
    • EPS
      ₹3.62
    • Fertiliser Production Volumes
      1,34,355 MT

    9M FY26

    4
    • Revenue
      ₹1,472.3 Cr
      YoY+93.1%
    • EBITDA
      ₹185.4 Cr
      YoY+69.5%
    • PAT
      ₹90.4 Cr
      YoY+109.3%
    • EPS
      ₹10.32
      YoY+109.3%

    Segment breakdown

    Q3 FY26 Revenue Breakdown
    ₹615 Cr Total Revenue₹280 Cr Imported Fertilizers Revenue₹335 Cr Manufactured Fertilizers Revenue
    List

    Capital allocation

    1
    medium confidence
    CategoryHeadline
    Capex

    Capex disclosed

    mix of internal accruals and some loan from the banks for Maharashtra project

    Guidance & targets

    8
    CategoryTargetPriority
    Margin
    EBITDA Margin on Own Manufactured Products
    13% to 14%
    High
    Capacity
    Sagar Expansion Commencement
    First week of April
    Medium
    Capacity
    Dhule Phase 1 Trial Production
    July
    High
    Capacity
    Dhule Phase 1 Commercial Production
    October
    High
    Capacity
    SSP, Phosphoric Acid, NPK (Dhule) Commercialization
    October 26
    High
    Revenue
    FY27 Revenue Growth
    more than 50%
    High
    Revenue
    Dhule Plant Additional Revenue Potential
    more than ₹2,000 crore
    High
    Revenue
    Q4 FY26 Revenue Momentum
    similar momentum
    Medium

    Sagar Plant Commercialization

    Q1 FY27 (April 2026)
    CurrentCivil work completed, equipment in transit, trial runs planned for March
    TargetCommercial operations commenced

    Why it matters

    This expansion will add 90,000 MT DAP NPK capacity and sulfuric acid, contributing significantly to increased production and revenue.

    Our attempt will be to start operations in the first week of April, although it could be a month earlier or later.

    How to verify

    guidance_and_targets[metric='Sagar Expansion Commencement']

    Risks & concerns

    3
    RiskSeverity

    Margin compression due to imported products

    Overall EBITDA margins appear lower due to the inclusion of lower-margin imported fertilizers (2.5-3% vs 13-14% for own production), which are necessary to meet demand and expand market presence.Management acknowledged

    medium

    Inventory buildup due to logistics issues

    Outward movement of fertilizers was interrupted due to railway transportation being prioritized for agriculture crop movement, leading to piled-up inventory, but expected to be resolved within the quarter.Management acknowledged

    low

    Inability to fully meet demand with own production

    Existing plants are operating at 100% capacity, necessitating imports to offer a complete product bouquet and meet rising demand for NPK variants.Management acknowledged

    medium

    Q&A highlights

    8

    “We have consistently maintained that almost 45% of our annual revenue is in the form of current assets. This trend has not changed, even during the current quarter.”

    Provides insight into the company's working capital efficiency and management strategy, indicating stability in this key area.

    asked by Nitin Kaushik

    2 min read5 chapters

    Detailed Narrative

    01

    Capacity Expansion and Backward Integration Progress

    Madhya Bharat Agro Products is making significant progress on its capacity expansion and backward integration plans. At Dhule, Maharashtra, an integrated complex fertilizer plant with 3.3 LMT DAP NPK and 3.3 LMT SSP capacity, along with phosphoric and sulfuric acid integration, is planned for commissioning in H1 FY27. Concurrently, the Banda, Sagar facility is expanding DAP NPK capacity by 90,000 MT and sulfuric acid capacity, with commissioning expected in Q1 FY27. These projects are crucial for scaling operations, improving cost efficiency, and strengthening the company's market position across key fertilizer markets.

    02

    Robust Q3 and 9M FY26 Financial Performance

    The company delivered its highest-ever quarterly revenue of ₹612.4 crores in Q3 FY26, marking a substantial 115.9% YoY growth. EBITDA also reached a record ₹66.5 crores, up 68.4% YoY, leading to a 77.7% increase in PAT to ₹31.8 crores. For the nine months ended December 2025, revenue stood at ₹1,472.3 crores (up 93.1%), EBITDA at ₹185.4 crores (up 69.5%), and PAT doubled to ₹90.4 crores (up 109.3%). Operational excellence was demonstrated with record fertilizer production volumes of 1,34,355 MT and high utilization rates of 109% for SSP and 115% for NPK/DAP operations.

    03

    Agriculture Sector Tailwinds and Policy Support

    The agriculture environment remained supportive during the quarter, with strong Rabi sowing progress, favorable monsoon performance, and comfortable reservoir levels, leading to over 614 lakh hectares of crop coverage. Government policies, including approved nutrient-based subsidy rates for Rabi 2025-26 (with a 2% outlay increase), the National Pulses Mission, and MSP hikes for Rabi crops, are expected to bolster farmer income and fertilizer demand. These initiatives, coupled with enforcement actions against black-marketing and promotion of balanced nutrient use, create a positive backdrop for the fertilizer industry.

    04

    Margin Dynamics: Impact of Imports vs. Own Production

    While overall EBITDA margins appeared squeezed during the quarter, management clarified that this was primarily due to the inclusion of lower-margin imported fertilizers. Imported products typically yield returns of approximately 2.5% to 3%, significantly lower than the 13% to 14% EBITDA margins achieved on the company's own manufactured products. The company resorts to imports to meet rising demand for customized NPK variants and expand market presence, as its existing plants are operating at 100% capacity. Management expects to maintain 13-14% margins on its own production going forward.

    05

    Working Capital and Inventory Management

    The company consistently maintains approximately 45% of its annual revenue in current assets, a trend that remained stable this quarter. Subsidy receivables typically range from two months during peak season to four months off-season, with all claims up to the fourth week of November received from the Government of India. An increase in finished goods inventory was noted due to temporary logistics issues, specifically railway transportation being prioritized for agriculture crop movement. Management expects these issues to be resolved and the accumulated inventory dispatched within the current quarter.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.